Interval breast cancers in a community screening programme: frequency, radiological classification and prognostic factors

European Journal of Cancer Prevention

Volumn 17, Issue 5, 2008, Pages 414-421

  Baré, Marisa ^a,f   Sentís, Melcior ^b   Galceran, Jaume ^c   Ameijide, Alberto ^d   Andreu, Xavier ^e   Ganau, Sergi ^b   Tortajada, Lidia ^b   Planas, Jaume ^b  

^a Epidemiology Unit   (Spain)

^b Breast Imaging Unit   (Spain)

^c Tarragona Cancer Registry   (Spain)

^d Reseach Institut on Health Sciences   (Spain)

^e UDIAT CD   (Spain)

^f Servicio de Oncología Médica   (Spain)

Author keywords

Breast cancer; Interval cancers; Mass screening; Prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SPAIN; BREAST TUMOR; CARCINOMA IN SITU; CLASSIFICATION; COMMUNITY CARE; DIAGNOSTIC ERROR; EVALUATION; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PAGET NIPPLE DISEASE; RADIOGRAPHY; STANDARD; STATISTICS;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMMUNITY NETWORKS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PROGNOSIS; SPAIN;

EID: 56149090234     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f75ef5     Document Type: Article

References (32)

1. Amos AF, Kavanagh AM, Cawson J; The Radiology Quality Assurance Group of BreastScreen Victoria (2000). Radiological review of interval cancers in an Australian mammographic screening programe. J Med Screen 7:184-189.
2. Baré M (2005). Prognostic factors in a population-based breast cancer screening programme (Thesis). Bellaterra: Universitat Autònoma de Barcelona
3. Baré M (2006). Accessible at URL: http://www.cspt.es/ webcsptangles/cribratge /BCSProgram.pdf
4. Baré M, Bonfill X, Andreu X, on behalf of the Breast Cancer Screening Programme (BCSP) of Sabadell-Cerdanyola Research Group (2006). Relationship between the method of detection and prognostic factors for breast cancer in a community with a screening programme. J Med Screen 13:183-191.
5. Bulliard JL, Sasieni P, Klabunde C, De Landtsheer JP, Yankaskas BC, Fracheboud J (2006). Methodological issues in international comparison of interval breast cancers. Int J Cancer 119:1158-1163.
6. Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, Blamey RW. (1995). Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol 68:450-453.
7. Cowan W, Angus B, Gray J, Lunt LG, al-Tamimi SR (2000). A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol 53:140-146.
8. Elston CW, Ellis IO (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410.
9. Everington D, Gilbert FJ, Tyack C, Warner J (1999). The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 6: 21-27.
10. Fracheboud J, de Koning HJ, Beemsterboer PMM, Boer R, Verbeek AL, Hendriks JH, et al. (1999). Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81:912-917.
11. Frisell J, von Rosen A, Wiege M, Nilsson B, Goldman S (1992). Interval cancer and survival: a randomized cancer screening trial in Stockholm. Breast Cancer Res Treat 24:11-16.
12. Galea MH, Blamey RW, Elston CE, Ellis IO (1992). The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207-219.
13. Ganry OF, Peng J, Raverdy NL, Dubreuil AR (2001). Interval cancers in a French breast cancer-screening programme (Somme Department). Eur J Cancer Prev 10:269-274.
14. Hofvind S, Skaane P, Vital B, Wang H, Thoresen S, Eriksen L, et al. (2005). Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program. Radiology 237:437-443.
15. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F (1992). Interval cancers in the Malmo mammographic screening trial: radiographic appearance and prognostic considerations. AJR 159:287-294.
16. International Union Against Cancer-IUAC (2005). TNM Classification of Malignant Tumours. In: Sobin LH, Wittekind Ch, editors. 6th ed. Berlin: Springer Verlag.
17. Liston J, Wilson R, editors. (2005). Quality assurance guidelines for breast cancer screening radiology. NHSBSP publication No 59. Sheffield: NHS Cancer Screening Programmes.
18. McCann J, Britton PD, Warren RML, Unam G, on behalf of the East Anglian Breast Screening Programme (2001). Radiological peer review of interval cancers in the East Anglian breast screening programme: what are we missing? J Med Screen 8:77-85.
19. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP (1989). The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59:929-932.
20. Perry N, Broeders M, de Wolf C, Törnberg S (2001). European guidelines for quality assurance in mammography screening. 3rd ed. Luxemburg: Office for official publications of the European Communities.
21. Porter GJR, Evans AJ, Burell HC, Lee AH, Ellis IO, Chakrabarti J (2006). Interval breast cancers: prognostic features and survival by subtype and time since screening. J Med Screen 13:115-122.
22. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, et al. (1999). Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91:2020-2028.
23. Raja MAK, Hubbard A, Salman AR (2001). Interval breast cancer: is it a different type of breast cancer? The Breast 10:100-108.
24. Saarenmaa I, Salmien T, Geiger U, Holli K, Isola J, Kärkkäinen A, et al. (1999). The visibility of cancer on earlier mammograms in a population-based screening programme. Eur J Cancer 35:1118-1122.
25. Séradour B, Wait S, Jacquemier J, Dubuc M, Piana L (1997). Modalities of reading of detection mammographies of the programme in the Bouches-du-Rhône. Results and costs 1990-1995 [in French]. J Radiol 78:49-54.
26. Taplin SH, Rutter CM, Elmore JG, Seger D, White D, Brenner RJ (2000). Accuracy of screening mammography using single versus independent double interpretation. AJR 174:1257-1262.
27. Taylor R, Supramaniam R, Rickard M, Estoesta J, Moreira C (2002). Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes. J Med Screen 9:20-25.
28. Taylor R, Page A, Bampton D, Estoesta J, Richard M (2004). Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years. J Med Screen 11:199-206.
29. Thurfjell EL, Lernevall A, Taube AAS (1994). Benefit of independent double reading in a population-based mammography screening program. Radiology 191:241-244.
30. Vettorazzi M, Stocco C, Chirirco A, Recanatini S, Saccon S, Mariotto R, et al. (2006). Quality control of mammography screening in the Veneto region. Evaluation of four programs at a local health unit level: analysis of the frequency and diagnostic pattern of interval cancers. Tumori 92:1-5.
31. Wang H, Bjurstam N, Bjorndal H, Braaten A, Eriksen L, Skaane P, et al. (2001). Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer 94:594-598.
32. World Health Organization (1981). Histological typing of breast tumours. 2nd ed. Geneva, Switzerland: World Health Organization.